Study to Evaluate the Organoleptic Perception of Oral Nutritional Supplements for Oncological Patients

Nutritional therapy is key to helping cancer patients get the nutrients they need to maintain body weight, strength, tissue and organ integrity, and face likely infections. Some cancer treatments work best when the patient is well nourished and has enough calories and macronutrients from food. According to the latest consensus, the first step in nutritional intervention is nutritional recommendations or dietary advice. These recommendations must be realized if the patient is capable of ingesting at least 75% of the nutritional requirements that correspond to them and, if there is no approach to an upcoming risk therapy. As long as the oral route is not damaged, in dietary advice this should always be the first option. Increasingly, laboratories specialized in nutritional products prepare and improve the composition of supplements. They are complete, specific and perfect to meet the dietary needs of patients who require it. But, to fulfill their function, they have to be ingested by people and for that they have to have good organoleptic characteristics, a very important nuance that is sometimes not taken into account in the manufacture of these products. It is the object of Adventia Pharma, S.L. develop new Oral Nutritional Supplements specific for cancer patients and that meet optimal organoleptic characteristics. For this reason, a pilot study will be carried out that will evaluate different sensory and organoleptic aspects of the prototypes of supplements developed by the company to determine the consumer's reaction to the products developed and subsequently be able to select the one with the greatest acceptance.

Sex

All

Minimum age

18 Years

Inclusion Criteria:

* Men and women from 18 years old.
* Patients diagnosed with cancer (any type) and who have started or are going to start with chemo and/or radiotherapy treatment with or without surgery.
* Adequate cultural level and understanding
* Agree to participate in the study

Exclusion Criteria:

* Subjects with severe infection or major surgery in the previous three months.
* Subjects with an infectious process at the time of the study.
* Subjects with insulin dependent diabetes.
* Subjects with dementia, mental illness or decreased cognitive function.
* Pregnant or breastfeeding women.
* Subjects with body mass index ≥ 40kg/m2.
* Subjects who rejects oral nutritional supplements.